Michael A.
Jacobs1, Li Pan2, Katarzyna J. Macura1,
Thorsten Feiweier3, Wilhelm Horger3, Christine Lorenz2,
Richard L. Wahl1
1The Russell H. Morgan Department of
Radiology and Radiological Science, The Johns Hopkins University School of
Medicine, Baltimore, MD, United States; 2Center for Applied
Medical Imaging, Siemens Corporation, Corporate Research, Baltimore,, MD,
United States; 3Siemens AG, Healthcare Sector, Magnetic Resonance,
Germany
By
using Whole Body MR and PET/CT approach to investigate metastatic disease can
lead a better understanding of cancer aggressiveness. Functional imaging such
as DWI/ADC, DCE-MR and 11C Choline PET is feasible and thus, combined DWI/ADC
mapping, and PET/CT provides radiological biomarkers of molecular environment
and could provide targets imaging treatment response.